EMEA-001344-PIP02-17
Key facts
| Invented name |
|
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0126/2018
|
| PIP number |
EMEA-001344-PIP02-17
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Prevention of cardiovascular events
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Zentiva, k.s.
Tel.: +420 267243574
E-mail: blanka.zoubkova@sanofi.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions/indications
|